Clinical Implications of Genetic Testing for Hereditary Breast and Ovarian Cancer Syndrome in the Era of Genomic Medicine: Clinician's Perspectives
Journal of Breast Disease
;
(2): 1-9, 2016.
Artículo
en Coreano
| WPRIM
| ID: wpr-646631
ABSTRACT
Hereditary breast and ovarian cancer syndrome accounts for approximately 5% to 10% of breast or ovarian cancers, with which the high-penetrant BRCA1/2 genes have been associated. With the recent development of next-generation sequencing (NGS), germline mutation testing and its related medical and surgical management have been rapidly changing. In this review, we summarize the current status and perspectives of NGS testing for not only BRCA1/2 but also the other breast and ovarian cancer susceptibility genes.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Neoplasias Ováricas
/
Mama
/
Neoplasias de la Mama
/
Pruebas Genéticas
/
Mutación de Línea Germinal
/
Secuenciación de Nucleótidos de Alto Rendimiento
/
Síndrome de Cáncer de Mama y Ovario Hereditario
Idioma:
Coreano
Revista:
Journal of Breast Disease
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS